Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Balanced Salt Solution vs Normal Saline in Pediatric Sepsis
NCT02336620Phase 3Completed
- Sponsor
- Ramathibodi Hospital
- Start
- Dec 2014
- Primary completion
- Jan 2017
- Modality
- Intravenous Solution
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of ringer's acetate in sepsis and septic shock (2 arms), sponsored by Ramathibodi Hospital. Primary endpoint: Incidence of hyperchloremic metabolic acidosis at 48 hours. Started Dec 2014; status: completed.
02
Drugs
ringer's acetate
03
Conditions
sepsisseptic shock
Beyond the preview
Go deeper on NCT02336620.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02336620.